Can Biolinq shine new light on measuring glucose? CEO Yang makes a case here and at DeviceTalks West

In this podcast episode, Biolinq CEO Rich Yang reveals that he once vetoed his VC firm’s investment in the company. But something obviously changed his mind about the company’s novel approach to monitoring glucose and, hopefully, hormones and other critical elements.

If you like what you hear, join us at DeviceTalks West where Yang will give a presentation about Biolinq’s unique technology. Register now at West.DeviceTalks.com and use the code DTPOD25 to save 25%.

MassDevice Editor Chris Newmaker shares his Newmarker’s Newsmakers of the week – Route 92, Stryker, Medtronic, Siemens Healthineers, Masimo and urology companies.

Thank you for listening to the DeviceTalks Weekly podcast.

Subscribe to the DeviceTalks Podcast Network.